Your browser doesn't support javascript.
loading
MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.
Ho, Jar-Yi; Hsu, Ren-Jun; Liu, Jui-Ming; Chen, Szu-Chi; Liao, Guo-Shiou; Gao, Hong-Wei; Yu, Cheng-Ping.
Afiliação
  • Ho JY; Department of Pathology, and Graduate Institute of Pathology and Parasitology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Hsu RJ; Department of Pathology, and Graduate Institute of Pathology and Parasitology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Liu JM; Biobank Management Center of Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Chen SC; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
  • Liao GS; Division of Urology, Department of Surgery, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.
  • Gao HW; Department of Pathology, and Graduate Institute of Pathology and Parasitology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Yu CP; Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Oncotarget ; 8(14): 22443-22459, 2017 Apr 04.
Article em En | MEDLINE | ID: mdl-27705918
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Sistema de Sinalização das MAP Quinases / Proteínas Supressoras de Tumor / MicroRNAs / Carcinogênese / GTP Fosfo-Hidrolases Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Sistema de Sinalização das MAP Quinases / Proteínas Supressoras de Tumor / MicroRNAs / Carcinogênese / GTP Fosfo-Hidrolases Idioma: En Ano de publicação: 2017 Tipo de documento: Article